Currency In JPY
| Previous Close | 2,625 |
| Open | 2,576.5 |
| Day High | 2,576.5 |
| Day Low | 2,576.5 |
| 52-Week High | 2,912 |
| 52-Week Low | 2,109 |
| Volume | 1.03M |
| Average Volume | 1.29M |
| Market Cap | 1.35T |
| PE | 16.58 |
| EPS | 155.37 |
| Moving Average 50 Days | 2,578.96 |
| Moving Average 200 Days | 2,513.44 |
| Change | -48.5 |
Kyowa Kirin to Regain Control of Rocatinlimab Development and Commercialization Program, Demonstrating Strong Commitment to Address High Unmet Medical Need in Atopic Dermatitis
GlobeNewswire Inc.
Jan 30, 2026 1:00 PM GMT
Kyowa Kirin affirms commitment to developing rocatinlimab as a life-changing differentiated asset with significant market potential.Rocatinlimab’s novel approach as an investigational T-cell rebalancing therapy directly targeting the OX40 receptor ex